期刊文献+

肥胖因素对异丙酚镇静效力的影响 被引量:7

Effect of obesity on potency of propofol for sedation
原文传递
导出
摘要 目的 评价肥胖因素对异丙酚镇静效力的影响.方法 选择全身麻醉下行择期手术患者60例,性别不限,年龄35~55岁,ASA分级Ⅰ或Ⅱ级.根据BMI将患者分为2组(n=30):正常体重组(C组),BMI<25 kg/m2;肥胖组(O组),BMI 30~40 kg/m2.靶控输注异丙酚,初始血浆靶浓度为1.2 μg/ml,达到血浆靶浓度30 s后增加0.3 μ g/ml,直至患者意识消失(OAA/S评分=1分).记录各阶段异丙酚的血浆靶浓度,采用概率单位法计算异丙酚使患者意识消失的半数有效浓度(EC50)及95%可信区间.结果 C组和O组异丙酚使患者意识消失的EC50及95%可信区间分别为3.82(3.73~3.90)和3.29(3.20~3.37)μg/ml.与C组相比,O组EC50降低(P<0.05).结论 肥胖因素可增强异丙酚的镇静效力. Objective To evaluate the effect of obesity on the potency of propofol for sedation.Methods Sixty patients of both sexes, aged 35-55 yr, of American Society of Anesthesiologists physical status Ⅰ or Ⅱ , scheduled for elective operation under general anesthesia, were enrolled in the study.The patients were divided into 2 groups (n=30 each) according to the body mass index (BMI) : normal body weight (BMI 〈 25 kg/m2) group (group C) and obesity (BMI 30-40 kg/m2) group (group O).No patients received premedication.Propofol was given by target-controlled infusion.The initial target plasma concentration of propofol was set at 1.2 μg/ml.After the target concentration was steadily maintained for 30 s, it was increased in 0.3 μg/ml increment until the patients lost consciousness (OAA/S score =1).The target plasma concentration of propofol was recorded during each period.The median effective concentration (EC50) and 95% confidence interval of propofol for loss of consciousness was calculated using probit analysis.Results The EC50 and 95% confidence interval of propofol for loss of consciousness were 3.82 (3.73-3.90) and 3.29 (3.20-3.37) μg/ml in group C and group O, respectively.Compared with group C, the EC50 was significantly decreased in group O (P〈0.05).Conclusion Obesity can enhance the potency of propofol for sedation.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2015年第11期1368-1369,共2页 Chinese Journal of Anesthesiology
关键词 肥胖症 二异丙酚 剂量效应关系 药物 清醒镇静 Obesity Propofol Dose-response relationship,drug Conscious sedation
  • 相关文献

参考文献7

  • 1Ingrande J, Lemmens HJ. Dose adjustment of anaesthetics in the morbidly obese[ J]. Br J Anacsth,2010,105 suppl 1 :i16-i23.
  • 2Hanley MJ, Abernethy DR, Greenblatt DJ. Effect of obesity on the pharmacokinetics of drugs in humans [ J ]. Clin Pharmacoki- net,2010,49(2) :71-87.
  • 3Cheah MH, Kam PC. Obesity: basic science and medical as- pects relevant to anaesthetists [ J]. Anaesthesia, 2005,60 (10) : 1009-1021.
  • 4Kelly T, Yang W, Chen CS, et al. Global burden of obesity in 2005 and projections to 2030[J]. Int J Obes,2008,32(9): 1431-1437.
  • 5Glen JB. The development of Diprifusor: a TCI system for prapo- fol[ Jl. Anesthesia, 1998,53 suppl 1 : 13-21.
  • 6刘芳,徐志鹏,岳云,叶铁虎,张炳熙,左明章,徐铭军,郝绒绒,徐原,杨宁,车向明.靶控输注异丙酚意识消失时血浆和效应室靶浓度的EC(50)与脑电双频谱指数的关系 多中心大样本临床研究[J].中华麻醉学杂志,2007,27(4):324-327. 被引量:46
  • 7Xu Z, Liu F, Yue Y, et al. Cs0 for propofol-remifentanil tar- get-controlled infusion and bispectral index at loss of conscious- ness and response to painful stimulus in Chinese patients: a rnul- ticenter clinical trial[ J ]. Anesth Analg, 2009,108 (2) : 478-483.

二级参考文献5

  • 1Milne SE, Tory A, Irwin MG, et al. Relationship between bispectral index, auditory evoked potential index and effect-site EC50 for propofol at two clinical end-points. Br J Anaesth, 2003, 90:127-131.
  • 2Swinhoe CF, Peacock JE, Glen JB, et al. Evaluation of the predictive performance of a "Diprifusor" TCI system. Anaesthesia, 1998, 53 Supple 1:61-67.
  • 3Coetzee iF, Glen JB, Wium CA, et al. Pharmacokinetic model selection for target-controned infusion of propfol. Anesthesiology, 1995, 82: 1328- 1345.
  • 4Tackely RM, Lewis GTR, Roberts CP, et al. Computer eontroned infusion of propofol. Br J Anaesth, 1989,62:46-53.
  • 5于布为,彭章龙,赵永泉.高龄病人异丙酚分步TCI时效应室浓度及BIS的变化[J].中华麻醉学杂志,2002,22(12):711-714. 被引量:44

共引文献45

同被引文献55

引证文献7

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部